Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells.

Ferret PJ, Soum E, Negre O, Wollman EE, Fradelizi D.

Biochem J. 2000 Mar 15;346 Pt 3:759-65.

2.
3.

Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injury.

Gon Y, Sasada T, Matsui M, Hashimoto S, Takagi Y, Iwata S, Wada H, Horie T, Yodoi J.

Life Sci. 2001 Mar 9;68(16):1877-88.

PMID:
11292065
4.

Differential expression of glutaredoxin and thioredoxin during monocytic differentiation.

Takashima Y, Hirota K, Nakamura H, Nakamura T, Akiyama K, Cheng FS, Maeda M, Yodoi J.

Immunol Lett. 1999 Jun 1;68(2-3):397-401.

PMID:
10424449
5.
6.

Elevation of manganese superoxide dismutase gene expression by thioredoxin.

Das KC, Lewis-Molock Y, White CW.

Am J Respir Cell Mol Biol. 1997 Dec;17(6):713-26.

PMID:
9409558
7.

Thioredoxin induced antioxidant gene expressions in human lens epithelial cells.

Yegorova S, Yegorov O, Lou MF.

Exp Eye Res. 2006 Oct;83(4):783-92. Epub 2006 May 19.

PMID:
16712839
8.

Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.

Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV.

Oncogene. 2001 Jul 12;20(31):4235-48.

9.

Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt.

Kaimul Ahsan M, Nakamura H, Tanito M, Yamada K, Utsumi H, Yodoi J.

Free Radic Biol Med. 2005 Dec 15;39(12):1549-59. Epub 2005 Aug 15.

PMID:
16298680
10.
11.

Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells.

Dugas N, Mossalayi MD, Calenda A, Léotard A, Bécherel P, Mentz F, Ouaaz F, Arock M, Debré P, Dornand J, Dugas B.

Blood. 1996 Nov 1;88(9):3528-34.

12.

Protection against reperfusion-induced arrhythmias by human thioredoxin.

Aota M, Matsuda K, Isowa N, Wada H, Yodoi J, Ban T.

J Cardiovasc Pharmacol. 1996 May;27(5):727-32.

PMID:
8859944
13.

Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

Soini Y, Kahlos K, Näpänkangas U, Kaarteenaho-Wiik R, Säily M, Koistinen P, Pääakkö P, Holmgren A, Kinnula VL.

Clin Cancer Res. 2001 Jun;7(6):1750-7.

14.

Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl.

Andoh T, Chock PB, Murphy DL, Chiueh CC.

Mol Pharmacol. 2005 Nov;68(5):1408-14. Epub 2005 Aug 12.

15.

Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.

Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL.

Mol Cancer Res. 2007 Jan;5(1):95-108.

16.
17.

Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells.

Ravi D, Muniyappa H, Das KC.

J Biol Chem. 2005 Dec 2;280(48):40084-96. Epub 2005 Sep 13.

18.

Roles of thioredoxin in nitric oxide-dependent preconditioning-induced tolerance against MPTP neurotoxin.

Chiueh CC, Andoh T, Chock PB.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):96-102. Review.

PMID:
16005485
19.

Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp.

Lee SH, Kim WS, Lee SH, Oh JW, Lee HM, Jung HH, Jang JW, Jun YJ, Cho WJ, Jhun HS.

Acta Otolaryngol. 2005 Aug;125(8):877-82.

PMID:
16158536
20.

Supplemental Content

Support Center